SARTORIUS STEDIM BIOTECH Company Sartorius Stedim Biotech
Equities
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 248.6 EUR | -1.54% |
|
-1.62% | +3.80% |
| Mar. 26 | Transcript : Sartorius Stedim Biotech S.A. - Shareholder/Analyst Call | |
| Mar. 12 | SARTORIUS STEDIM BIOTECH : Jefferies remains its Buy rating | ZD |
Business Summary
For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis.
With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Number of employees: 10,662
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Biopharmaceuticals
100.0
%
| 3,493 | 100.0 % | 2,776 | 100.0 % | -20.53% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
35.1
%
| 1,215 | 34.8 % | 973 | 35.1 % | -19.90% |
EMEA
26.7
%
| 906 | 25.9 % | 741 | 26.7 % | -18.17% |
Asia Pacific
10.4
%
| 345 | 9.9 % | 288 | 10.4 % | -16.34% |
Germany
9.1
%
| 299 | 8.6 % | 253 | 9.1 % | -15.47% |
China
6.9
%
| 377 | 10.8 % | 191 | 6.9 % | -49.38% |
South Korea
5.4
%
| 175 | 5.0 % | 149 | 5.4 % | -14.71% |
France
3.6
%
| 114 | 3.3 % | 100 | 3.6 % | -12.80% |
Americas
2.9
%
| 63 | 1.8 % | 81 | 2.9 % | +28.57% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
| Chairman | 59 | 07-06-28 | |
| Chief Tech/Sci/R&D Officer | 59 | 09-04-28 | |
Petra Kirchhoff
IRC | Investor Relations Contact | 55 | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
| Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
Lothar Kappich
BRD | Director/Board Member | 67 | 17-09-13 |
Pascale Boissel
BRD | Director/Board Member | 57 | 19-03-25 |
| Chief Tech/Sci/R&D Officer | 59 | 09-04-28 | |
| Director/Board Member | 62 | 15-04-06 | |
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 92,180,190 | 29,470,560 ( 31.97 %) | 15,191 ( 0.0165 %) | 31.97 % |
Company contact information
Sartorius Stedim Biotech SA
Zone Industrielle Les Paluds Avenue de Jouques
13400, Aubagne
+33 4 42 84 56 00
http://www.sartorius.com
Group companies
| Name | Category and Sector |
|---|---|
Sartorius Stedim Biotech GmbH
 Sartorius Stedim Biotech GmbH Medical SpecialtiesHealth Technology Part of Sartorius AG, Sartorius Stedim Biotech GmbH is a German company that produces and sells laboratory equipment for the biopharmaceutical industry. The private company is based in Goettingen, Germany. The company was founded in 2007. The CEO is Uwe Becker. |
Medical Specialties
|
Sector
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
248.6
EUR
Average target price
264.6
EUR
Spread / Average Target
+6.45%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.80% | 26.11B | |
| -4.01% | 105B | |
| -4.77% | 66.74B | |
| +7.87% | 52.63B | |
| +16.18% | 47.48B | |
| +1.25% | 39.68B | |
| +7.17% | 27.78B | |
| -1.23% | 26.27B | |
| +11.64% | 25.38B | |
| -0.33% | 25.08B |
- Stock Market
- Equities
- DIM Stock
- Company Sartorius Stedim Biotech
